Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07503171 · ClinicalTrials.gov registry record
Hypoxia and Hemodilution Testing in Healthy Adult Volunteers
A clinical trial, sponsored by Nihon Kohden.
- Not yet
- Registry status
- 7
- Enrollment target
NCT07503171: Clinical Trial study, sponsored by Nihon Kohden.
NCT07503171 is a clinical trial that has not yet begun recruiting, run by Nihon Kohden. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07503171 has not yet begun recruiting, sponsored by Nihon Kohden.
- NOT YET RECRUITING
- Registry status
- 7 participants
- Enrollment target
Study Summary
This study will collect physiological measurements in healthy adult volunteers under controlled hypoxia and hemodilution conditions.
Primary Outcome
Collect device readings of oxygen saturation and hemoglobin concentration and reference values obtained from arterial blood samples analyzed using a multi-wavelength laboratory oximeter.
Interventions
- DEVICE Noninvasive Physiological Monitoring Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2026-04-02 |
| Est. Completion | 2028-01-31 |
What is known before NCT07503171 opens enrollment
NCT07503171 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Noninvasive Physiological Monitoring Device is the first listed.
NCT07503171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07503171 about?
NCT07503171 is a clinical study titled "Hypoxia and Hemodilution Testing in Healthy Adult Volunteers". This study will collect physiological measurements in healthy adult volunteers under controlled hypoxia and hemodilution conditions.
What is the current status of trial NCT07503171?
This trial is currently not yet recruiting. The enrollment target is 7 participants. The study started on 2026-04-02. Estimated completion is 2028-01-31.
What interventions are being tested in trial NCT07503171?
The interventions under investigation include: Noninvasive Physiological Monitoring Device (DEVICE).
Who is sponsoring clinical trial NCT07503171?
This trial is sponsored by Nihon Kohden, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI